Erasca (ERAS) Total Current Liabilities (2020 - 2026)

Erasca (ERAS) posted Total Current Liabilities of $26.7 million for Q1 2026, down 6.48% on a QoQ basis from $28.5 million in Q4 2025, and up 4.68% year-over-year from $25.5 million in Q1 2025.

Erasca (ERAS) Total Current Liabilities (2020 - 2026) Analysis & Trends

Erasca's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $26.7 million for Q1 2026.

  • Quarterly Total Current Liabilities rose 4.68% year-over-year to $26.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.7 million (up 4.68% YoY) and the FY2025 annual result came in at $28.5 million, down 9.19% from the prior year.
  • Total Current Liabilities was $26.7 million for Q1 2026 at Erasca, down from $28.5 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $48.7 million in Q4 2022 and bottomed at $21.4 million in Q1 2022.
  • A 5-year average of $28.0 million and a median of $26.7 million in 2023 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Current Liabilities soared 85.68% — and 2023, when it tumbled 46.28%.
  • Erasca's Total Current Liabilities stood at $48.7 million in 2022, then plunged by 46.28% to $26.2 million in 2023, then grew by 20.03% to $31.4 million in 2024, then slipped by 9.19% to $28.5 million in 2025, then decreased by 6.48% to $26.7 million in 2026.
  • Business Quant data shows ERAS's Total Current Liabilities at $26.7 million in Q1 2026, $28.5 million in Q4 2025, and $28.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Erasca 5.89 Bn 5.89 Bn - 26.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 26.66 Mn
Dec 31, 2025 28.51 Mn
Sep 30, 2025 28.71 Mn
Jun 30, 2025 28.15 Mn
Mar 31, 2025 25.47 Mn
Dec 31, 2024 31.40 Mn
Sep 30, 2024 30.03 Mn
Jun 30, 2024 24.89 Mn
Mar 31, 2024 30.24 Mn
Dec 31, 2023 26.16 Mn
Sep 30, 2023 26.73 Mn
Jun 30, 2023 23.29 Mn
Mar 31, 2023 25.52 Mn
Dec 31, 2022 48.69 Mn
Sep 30, 2022 27.68 Mn
Jun 30, 2022 22.32 Mn
Mar 31, 2022 21.39 Mn
Dec 31, 2021 26.22 Mn
Sep 30, 2021 19.59 Mn
Jun 30, 2021 17.91 Mn